Stay updated on Pembrolizumab+Cabozantinib in Metastatic Renal Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab+Cabozantinib in Metastatic Renal Cell Carcinoma Clinical Trial page.

Latest updates to the Pembrolizumab+Cabozantinib in Metastatic Renal Cell Carcinoma Clinical Trial page
- Check2 days agoChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.3, signaling a newer version of the study record. This update appears to be a metadata revision rather than a change to study content or functionality.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page now indicates that recruitment has ended by stating 'No longer looking for participants' and adds sections to help readers read a study record, view common questions, and learn how to join. It also standardizes the Intervention/Treatment heading and notes the new revision version v3.6.0.SummaryDifference0.4%

- Check23 days agoChange DetectedRevision tag updated from v3.5.4 to v3.5.5, indicating a new version of the study record. This update does not modify the study text or results shown on the page.SummaryDifference0.0%

- Check44 days agoChange DetectedA new CABOSUN trial citation was added to Publications with Revision: v3.5.4, and the prior Erratum entry (Revision: v3.5.3) was removed.SummaryDifference0.1%

- Check65 days agoChange DetectedThe page’s references section now shows an updated CABOSUN trial citation line including the associated erratum entries. The site footer revision/version tag was also updated from v3.5.0 to v3.5.3.SummaryDifference0.1%

- Check101 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. No changes to study content are evident in the screenshot.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab+Cabozantinib in Metastatic Renal Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Cabozantinib in Metastatic Renal Cell Carcinoma Clinical Trial page.